Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against <i>Acinetobacter baumannii</i> in Patients with Hospital-Acquired Pneumonia

Cefoperazone/sulbactam (CPZ/SUL) is a β-lactam and β-lactamase inhibitor combination therapy for the treatment of respiratory tract infections. Using data from a prospective, multiple-center, open-label clinical trial in 54 patients with hospital-acquired pneumonia or ventilator-associated pneumonia...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yingjie Zhou, Jing Zhang, Yuancheng Chen, Jufang Wu, Beining Guo, Xiaojie Wu, Yingyuan Zhang, Minggui Wang, Ru Ya, Hao Huang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-05-01
coleção:	Antibiotics
Assuntos:	cefoperazone sulbactam pharmacokinetic/pharmacodynamic combined PK/PD index hospital-acquired pneumonia <i>Acinetobacter baumannii</i>
Acesso em linha:	https://www.mdpi.com/2079-6382/11/5/703
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!